Income Statement

AURINIA PHARMACEUTICALS INC.

AUPH
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY
Revenue
283.06 235.13 175.51 134.03 45.61 50.12
Cost of Revenue
32.67 28.25 14.15 5.66 1.09 -
Gross Profit
250.39 206.89 161.37 128.37 44.51 50.12
Operating Expenses
134.30 192.81 244.68 241.37 222.58 154.41
Research & Development
32.51 20.79 49.64 45.00 51.14 50.33
Selling, General & Administrative
101.79 172.03 195.04 196.37 171.44 95.98
Other Operating Expenses
- - - - - -
Operating Income
116.09 14.07 -83.31 -113.01 -178.06 -104.29
Non-Operating Income
1.93 6.62 -5.84 -6.65 2.14 -1.52
Interest Income
13.57 16.97 - - 0.53 1.52
Interest Expense
- - 2.78 - - -
Other Non-Op Income / Expense
- - - - - -
Income Before Tax
114.16 7.45 -77.47 -106.35 -180.21 -102.77
Income Tax Expense
-173.05 1.70 0.55 1.83 0.76 -0.09
Non-Controlling Interest
- - - - - -
Net Income
287.20 5.75 -78.02 -108.18 -180.97 -102.68
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY
Depreciation & Amortization
- - - - - -
EBITDA
135.54 33.52 -71.67 -110.30 -178.06 -104.29
Earnings Per Share (Basic)
2.14 0.04 -0.54 -0.76 -1.40 -
Diluted EPS
2.07 0.04 -0.54 -0.76 -1.40 -
Weighted Average Shares
134.37 143.06 143.24 141.92 - -
Diluted Weighted Avg Shares
138.70 146.19 143.24 141.92 - -
Comprehensive Income
287.25 5.84 -77.69 -108.39 -181.01 -